IBRX
ImmunityBio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.08
−1.34%0
Insider buys (3m)
5
Insider sells (3m)
-$3.8M
Net value (3m)
+17.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 6, 2026 | Selecky Christobel · director | M-Exempt | 35,064 | $2.98 |
| Jul 6, 2026 | Selecky Christobel · director | M-Exempt | 124,414 | $2.99 |
| Jul 6, 2026 | Selecky Christobel · director | Sale | 159,478 | $9.02 |
| Jul 6, 2026 | Cohen Cheryl · director | Sale | 131,210 | $9.50 |
| Jul 6, 2026 | Cohen Cheryl · director | M-Exempt | 55,979 | $2.98 |
| Jul 1, 2026 | Selecky Christobel · director | Sale | 1,000 | $9.00 |
| Jul 1, 2026 | Selecky Christobel · director | M-Exempt | 300 | $2.99 |
| Jul 1, 2026 | Selecky Christobel · director | M-Exempt | 700 | $2.98 |
| Jul 1, 2026 | Selecky Christobel · director | Sale | 95,722 | $9.01 |
| Jul 1, 2026 | Selecky Christobel · director | M-Exempt | 30,000 | $2.84 |
| Jul 1, 2026 | Selecky Christobel · director | M-Exempt | 33,549 | $2.99 |
| Jul 1, 2026 | Selecky Christobel · director | M-Exempt | 32,173 | $2.98 |
| Jun 26, 2026 | Simon Barry J. · director | Sale | 25,000 | $7.88 |
| Jun 10, 2026 | Selecky Christobel · director | A-Award | 65,600 | $7.25 |
| Jun 10, 2026 | Cohen Cheryl · director | A-Award | 65,600 | $7.25 |
| Jun 10, 2026 | Clark Wesley · director | A-Award | 65,600 | $7.25 |
| Jun 10, 2026 | MAXWELL LINDA · director | A-Award | 65,600 | $7.25 |
| Jun 10, 2026 | Wendel Bruce · director | A-Award | 65,600 | $7.25 |
| Jun 10, 2026 | BLASZYK MICHAEL D · director | A-Award | 65,600 | $7.25 |
| Jun 5, 2026 | Simon Barry J. · director | Sale | 23,033 | $7.18 |
| Feb 26, 2026 | Simon Barry J. · director | Sale | 75,000 | $12 |
| Feb 24, 2026 | Adcock Richard · director, officer: CEO & President | F-InKind | 77,560 | $8.70 |
| Feb 24, 2026 | SOON-SHIONG PATRICK · director, 10 percent owner, officer: See remarks | F-InKind | 58,170 | $8.70 |
| Feb 24, 2026 | LAUER REGAN J · officer: Chief Accounting Officer | M-Exempt | 4,065 | $0.00 |
| Feb 24, 2026 | SOON-SHIONG PATRICK · director, 10 percent owner, officer: See remarks | M-Exempt | 114,329 | $0.00 |
| Feb 24, 2026 | Sachs David C. · officer: Chief Financial Officer | F-InKind | 20,682 | $8.70 |
| Feb 24, 2026 | Sachs David C. · officer: Chief Financial Officer | M-Exempt | 40,650 | $0.00 |
| Feb 24, 2026 | Selecky Christobel · director | Sale | 25,000 | $10 |
| Feb 24, 2026 | Selecky Christobel · director | M-Exempt | 25,000 | $2.98 |
| Feb 24, 2026 | LAUER REGAN J · officer: Chief Accounting Officer | F-InKind | 1,673 | $8.70 |
Institutional positioning
13F filings over the trailing two quarters
New 220Increased 288Reduced 163Sold out 47
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 34,083,262 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 26,346,443 | May 13, 2026 |
| STATE STREET CORP | Increased | 21,398,438 | Aug 7, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 17,863,911 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 17,708,103 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 16,322,844 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 15,691,579 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 15,127,714 | May 15, 2026 |
| D. E. SHAW & CO., INC. | New Position | 12,571,597 | May 15, 2026 |
| D. E. Shaw & Co., Inc. | Reduced | 11,551,019 | Aug 14, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 11,097,106 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 9,847,896 | Aug 12, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 8,696,276 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 8,371,661 | Aug 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 8,031,921 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 6, 2026